Gilead Ramps Up For Ambrisentan; Calls For 75 To 100 Sales Reps

 
• By Jessica Merrill

Company plans to go toe-to-toe with PAH competitors, CEO tells JP Morgan Healthcare Conference.

More from Archive

More from Pink Sheet